Pages

Wednesday, August 28, 2013

New CIRM payouts target muscular dystrophy, ALS, Huntington's Disease

... University and a small Peninsula company were among those winning cash Wednesday from California's stem cell research funding agency that could lead to therapies for Lou Gehrig's disease, muscular dystrophy and Huntington's Disease In all, the board ...

http://www.bizjournals.com/sanfrancisco/blog/biotech/2013/08/cirm-stem-cells-ips-als-huntingtons-md.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_33+%28Health+Insurance+Industry+News%29

No comments:

Post a Comment